State Street
KRTX

State Street’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

State Street’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-974,643
Closed -$308M – 4430
2023
Q4 		$308M Buy
974,643
+45,673
+5% +$8.88M 0.02% 634
2023
Q3 		$157M Buy
928,970
+113,684
+14% +$21.4M 0.01% 897
2023
Q2 		$177M Sell
815,286
-181,249
-18% -$38.8M 0.01% 863
2023
Q1 		$181M Buy
996,535
+20,858
+2% +$3.99M 0.01% 820
2022
Q4 		$192M Buy
975,677
+98,832
+11% +$21.2M 0.01% 778
2022
Q3 		$197M Sell
876,845
-311,592
-26% -$63.1M 0.01% 739
2022
Q2 		$150M Buy
1,188,437
+161,930
+16% +$18.6M 0.01% 898
2022
Q1 		$130M Buy
1,026,507
+187,142
+22% +$21.1M 0.01% 1108
2021
Q4 		$110M Sell
839,365
-23,024
-3% -$2.98M 0.01% 1235
2021
Q3 		$105M Buy
862,389
+136,202
+19% +$15.7M 0.01% 1217
2021
Q2 		$82.8M Buy
726,187
+19,135
+3% +$2.24M ﹤0.01% 1449
2021
Q1 		$85M Sell
707,052
-67,527
-9% -$7.65M ﹤0.01% 1359
2020
Q4 		$78.7M Sell
774,579
-25,057
-3% -$2.32M ﹤0.01% 1335
2020
Q3 		$61.8M Buy
799,636
+38,290
+5% +$3.26M ﹤0.01% 1310
2020
Q2 		$84.9M Buy
761,346
+533,111
+234% +$46.4M 0.01% 1088
2020
Q1 		$16.4M Buy
228,235
+107,968
+90% +$9.23M ﹤0.01% 1966
2019
Q4 		$9.06M Buy
120,267
+59,937
+99% +$2.63M ﹤0.01% 2576
2019
Q3 		$985K Buy
+60,330
New +$1.17M ﹤0.01% 3400

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

State Street's KRTX Position: Q1 2024 in Review

State Street sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 974,643 shares — an estimated $308M sold.

State Street first reported a position in KRTX in Q3 2019 and held it in 18 quarters. The position peaked at $308M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • State Street reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • State Street sold 974,643 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $308M.
  • State Street first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and held it in 18 quarters.
  • State Street's Karuna Therapeutics, Inc. Common Stock position peaked at $308M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on State Street's 13F filing for Q1 2024, filed 15 May 2024.